Glass House Brands (GLAS) Inventory (2020 - 2026)
Glass House Brands' (GLAS) quarterly Inventory came in at $31.5 million in Q1 2026, up 101.1% year-on-year from $15.7 million in Q1 2025, and up 20.25% on a QoQ basis from $26.2 million in Q4 2025.
Glass House Brands (GLAS) Inventory (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Inventory data on file, last reported at $31.5 million in Q1 2026.
- On a quarterly basis, Inventory rose 101.1% year-over-year to $31.5 million in Q1 2026; TTM through Mar 2026 was $31.5 million, a 101.1% increase from a year earlier, with the FY2025 full-year figure at $26.2 million, up 84.02% from the prior year.
- Inventory for Q1 2026 stood at $31.5 million, up from $26.2 million in the prior quarter.
- Over the last five years, Inventory for GLAS reached as high as $31.5 million in Q1 2026 and fell as low as $7.6 million in Q1 2022.
- Historically, Inventory has averaged $15.6 million across 5 years, with a median of $14.5 million in 2024.
- Across the five-year window, Inventory declined 23.64% in 2024 and jumped 101.1% in 2026, its largest moves.
- Year by year, Inventory stood at $11.0 million in 2022, then fell by 19.27% to $8.8 million in 2023, then jumped by 61.22% to $14.3 million in 2024, then surged by 84.02% to $26.2 million in 2025, then increased by 20.25% to $31.5 million in 2026.
- Per Business Quant data, the three most recent Inventory figures were $31.5 million in Q1 2026, $26.2 million in Q4 2025, and $19.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 1.36 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 2.55 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 8.91 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 178.30 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 3.93 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 64.50 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1.72 Bn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | 31.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.54 Mn |
| Dec 31, 2025 | 26.23 Mn |
| Sep 30, 2025 | 19.38 Mn |
| Jun 30, 2025 | 19.67 Mn |
| Mar 31, 2025 | 15.68 Mn |
| Dec 31, 2024 | 14.25 Mn |
| Sep 30, 2024 | 16.77 Mn |
| Jun 30, 2024 | 14.50 Mn |
| Mar 31, 2024 | 11.21 Mn |
| Dec 31, 2023 | 8.84 Mn |
| Sep 30, 2023 | 12.84 Mn |
| Jun 30, 2023 | 16.70 Mn |
| Mar 31, 2023 | 14.68 Mn |
| Dec 31, 2022 | 10.95 Mn |
| Sep 30, 2022 | 12.75 Mn |
| Jun 30, 2022 | 12.25 Mn |
| Mar 31, 2022 | 7.60 Mn |
| Dec 31, 2021 | 6.53 Mn |
| Sep 30, 2021 | 11.36 Mn |
| Jun 30, 2021 | 11.57 Mn |